Orazi A - Search Results

1

In vivo effects of recombinant human stem cell factor treatment. A morphologic and immunohistochemical study of bone marrow biopsies.

Orazi A, Gordon MS, John K, Sledge G Jr, Neiman RS, Hoffman R. Orazi A, et al. Am J Clin Pathol. 1995 Feb;103(2):177-84. doi: 10.1093/ajcp/103.2.177. Am J Clin Pathol. 1995. PMID: 7531939 Clinical Trial.

2

Acute leukemia with t(8;21) can express T-lineage-associated markers.

Orazi A, Kotylo P, Neiman RS. Orazi A, et al. Blood. 1992 Oct 1;80(7):1855-6. Blood. 1992. PMID: 1285763 Free article. No abstract available.

3

Recombinant human interleukin-3 and recombinant human granulocyte-macrophage colony-stimulating factor administered in vivo after high-dose cyclophosphamide cancer chemotherapy: effect on hematopoiesis and microenvironment in human bone marrow.

Orazi A, Cattoretti G, Schiró R, Siena S, Bregni M, Di Nicola M, Gianni AM. Orazi A, et al. Blood. 1992 May 15;79(10):2610-9. Blood. 1992. PMID: 1586713 Free article.

4

CD34 immunostaining of bone marrow biopsy specimens is a reliable way to classify the phases of chronic myeloid leukemia.

Orazi A, Neiman RS, Cualing H, Heerema NA, John K. Orazi A, et al. Am J Clin Pathol. 1994 Apr;101(4):426-8. doi: 10.1093/ajcp/101.4.426. Am J Clin Pathol. 1994. PMID: 7512785

5

The effect of in vivo administration of recombinant methionyl human stem cell factor on the number of human marrow hematopoietic stem cells.

Tong J, Gordon MS, Srour EF, Cooper RJ, Orazi A, McNiece I, Hoffman R. Tong J, et al. Among authors: orazi a. Trans Assoc Am Physicians. 1993;106:134-44. Trans Assoc Am Physicians. 1993. PMID: 7518622 Clinical Trial. No abstract available.

6

Terminal deoxynucleotidyl transferase staining in acute leukemia and normal bone marrow in routinely processed paraffin sections.

Orazi A, Cotton J, Cattoretti G, Kotylo PK, John K, Manning JT, Neiman RS. Orazi A, et al. Am J Clin Pathol. 1994 Nov;102(5):640-5. doi: 10.1093/ajcp/102.5.640. Am J Clin Pathol. 1994. PMID: 7524307

7

Prognostic significance of immunohistochemical proliferation markers (Ki-67/MIB-1 and proliferation-associated nuclear antigen), p53 protein accumulation, and neovascularization in clinical stage A nonseminomatous testicular germ cell tumors.

Albers P, Orazi A, Ulbright TM, Miller GA, Haidar JH, Donohue JP, Foster RS. Albers P, et al. Among authors: orazi a. Mod Pathol. 1995 Jun;8(5):492-7. Mod Pathol. 1995. PMID: 7545814

8

Correlation between presence of clonal rearrangements of immunoglobulin heavy chain genes and B-cell antigen expression in Hodgkin's disease.

Orazi A, Jiang B, Lee CH, English GW, Cattoretti G, John K, Neiman RS. Orazi A, et al. Am J Clin Pathol. 1995 Oct;104(4):413-8. doi: 10.1093/ajcp/104.4.413. Am J Clin Pathol. 1995. PMID: 7572791

9

In vivo administration of recombinant methionyl human stem cell factor expands the number of human marrow hematopoietic stem cells.

Tong J, Gordon MS, Srour EF, Cooper RJ, Orazi A, McNiece I, Hoffman R. Tong J, et al. Among authors: orazi a. Blood. 1993 Aug 1;82(3):784-91. Blood. 1993. PMID: 7687893 Free article.

10

Commentary: Immunohistochemistry represents a useful tool to study human cell engraftment in SCID mice transplantation models.

Orazi A, Braun SE, Broxmeyer HE. Orazi A, et al. Blood Cells. 1994;20(2-3):323-30. Blood Cells. 1994. PMID: 7749113

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

323 results

Search Page

Filters